TAG / CONFLICTS OF INTEREST

When conflicts of interest in major news coverage were exposed, CJR refused to respond, eroding public trust in media oversight.

Freedom exposes Dugan’s ties to an anti-Scientology hate group as he mocks media watchdogs, blocks critics and calls his own posts “BS.”

Dugan’s undisclosed ties to an anti-Scientology hate group reveal lapses in Wall Street Journal oversight—and explain why Americans’ trust in newspapers, TV and radio has plummeted to 28 percent.

Despite notoriously denying antidepressant harms—including devastating Post-SSRI Sexual Dysfunction (PSSD)—Anita Clayton is now leading the society that shapes the psychiatric industry’s drug policies.

Dugan’s undisclosed collaboration with a clandestine hate group shows his allegiance lies not with journalism, but with bigotry.

Purdue prepares to pay up, leaving unanswered questions about justice, accountability and how hundreds of thousands of lives might have been saved if regulators had acted sooner.

From cozy relationships to blockbuster approvals, a new FDA policy promises transparency after decades of industry entanglement. But is it too little, too late?

As an FDA executive, Cavazzoni handed Pfizer, her former employer, a record-setting number of approved drugs in one year. And now she’s back. There’s a reason they call it the “revolving door.”

According to the DOJ, this is the first time a management consulting firm has been held criminally responsible for advice resulting in the commission of a crime by a client—in this case, Purdue.

Paper’s fundraising arm raises millions from pro-drug advocacies. Editor Katharine Viner repays the courtesy with articles slamming life-saving drug rehabilitation.